Skip to main content
Annals of Surgery logoLink to Annals of Surgery
. 1989 Feb;209(2):219–224. doi: 10.1097/00000658-198902000-00013

Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited.

J M Klausner 1, I S Paterson 1, L Kobzik 1, C Rodzen 1, C R Valeri 1, D Shepro 1, H B Hechtman 1
PMCID: PMC1493902  PMID: 2644899

Abstract

Ischemia-induced renal injury is prevented by inhibition of thromboxane (Tx) synthesis. This protection was believed to be secondary to a high prostaglandin (PG)/TxA2 ratio. This study tests whether increasing the PG/Tx ratio by administration of vasodilating PGs protects the reperfused ischemic kidney. Anesthetized rats underwent right nephrectomy and 45 minutes of left renal pedicle clamping. Beginning 10 minutes before clamp release, animals were treated intravenously with the following: saline placebo (n = 10); the cyclooxygenase inhibitor ibuprofen (Ibu), 12.5 mg/Kg in a bolus (n = 8); a stable analogue of prostacyclin (PGI2), 500 ng/kg/minute for 2 hours (n = 9); PGE1, 400 ng/kg/minute for 2 hours (n = 8); the combination Ibu and PGI2 (n = 8) or PGE1 (n = 8). In saline treated ischemic controls, 5 minutes after reperfusion plasma, thromboxane (TxB2) and 6-keto-PGF1 levels were 2537 and 317 pg/ml, respectively--higher than the TxB2 and 6-keto-PGF1 levels of 750 and 80 pg/ml, respectively, in nephrectomized but nonischemic sham controls (n = 7) (p less than 0.05). In ischemic control animals at 24 hours, creatinine levels were 4.6 mg/dl, relative to 0.9 ml/dl in sham animals (p less than 0.05); the weight of the left (L) ischemic kidney relative to the right (R) normal kidney was 118%, compared with 99% in sham animals (p less than 0.05); and renal histology of ischemic control animals at 24 hours showed acute tubular necrosis (ATN) relative to normal findings in sham animals. Pretreatment with Ibu led to: TxB2 and 6-keto-PGF1 levels of 116 and 40 pg/ml, lower than those of sham animals (p less than 0.05); creatinine levels of 4.6 mg/dl, L/R renal weight of 119%; and ATN similar to that of ischemic controls. Treatment with a PGI2 analogue or PGE1 was not protective and led to increases in TxB2, 6-keto-PGF1, creatinine, L/R renal weight, and ATN similar to that of ischemic controls. The combination of Ibu and either PGI2 or PGE1 led to: reduced levels of TxB2 and 6-keto-PGF1 (p less than 0.05); attenuated increases in creatinine to 2.2 and 2.3 mg/dl, respectively (p less than 0.05); and limited ATN (p less than 0.05). These data indicate that the vasodilating PG protect the ischemic reperfused kidney only when Tx is inhibited.

Full text

PDF
219

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braide M., Blixt A., Bagge U. Leukocyte effects on the vascular resistance and glomerular filtration of the isolated rat kidney at normal and low flow states. Circ Shock. 1986;20(1):71–80. [PubMed] [Google Scholar]
  2. Brezis M., Rosen S., Silva P., Epstein F. H. Renal ischemia: a new perspective. Kidney Int. 1984 Oct;26(4):375–383. doi: 10.1038/ki.1984.185. [DOI] [PubMed] [Google Scholar]
  3. Casey K. F., Machiedo G. W., Lyons M. J., Slotman G. J., Novak R. T. Alteration of postischemic renal pathology by prostaglandin infusion. J Surg Res. 1980 Jul;29(1):1–10. doi: 10.1016/0022-4804(80)90002-5. [DOI] [PubMed] [Google Scholar]
  4. Defreyn G., Deckmyn H., Vermylen J. A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2. Thromb Res. 1982 Jun 15;26(6):389–400. doi: 10.1016/0049-3848(82)90311-5. [DOI] [PubMed] [Google Scholar]
  5. Doukas J., Hechtman H. B., Shepro D. Endothelial-secreted arachidonic acid metabolites modulate polymorphonuclear leukocyte chemotaxis and diapedesis in vitro. Blood. 1988 Mar;71(3):771–779. [PubMed] [Google Scholar]
  6. Downey G. P., Gumbay R. S., Doherty D. E., LaBrecque J. F., Henson J. E., Henson P. M., Worthen G. S. Enhancement of pulmonary inflammation by PGE2: evidence for a vasodilator effect. J Appl Physiol (1985) 1988 Feb;64(2):728–741. doi: 10.1152/jappl.1988.64.2.728. [DOI] [PubMed] [Google Scholar]
  7. Gaudet R. J., Alam I., Levine L. Accumulation of cyclooxygenase products of arachidonic acid metabolism in gerbil brain during reperfusion after bilateral common carotid artery occlusion. J Neurochem. 1980 Sep;35(3):653–658. doi: 10.1111/j.1471-4159.1980.tb03704.x. [DOI] [PubMed] [Google Scholar]
  8. Karlberg L., Norlén B. J., Ojteg G., Wolgast M. Impaired medullary circulation in postischemic acute renal failure. Acta Physiol Scand. 1983 May;118(1):11–17. doi: 10.1111/j.1748-1716.1983.tb07234.x. [DOI] [PubMed] [Google Scholar]
  9. Kaufman R. P., Jr, Anner H., Kobzik L., Valeri C. R., Shepro D., Hechtman H. B. Vasodilator prostaglandins (PG) prevent renal damage after ischemia. Ann Surg. 1987 Feb;205(2):195–198. doi: 10.1097/00000658-198702000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Komoriya K., Ohmori H., Azuma A., Kurozumi S., Hashimoto Y., Nicolaou K. C., Barnette W. E., Magolda R. L. Prostaglandin I2 as a potentiator of acute inflammation in rats. Prostaglandins. 1978 Apr;15(4):557–564. doi: 10.1016/0090-6980(78)90052-7. [DOI] [PubMed] [Google Scholar]
  11. Lelcuk S., Alexander F., Kobzik L., Valeri C. R., Shepro D., Hechtman H. B. Prostacyclin and thromboxane A2 moderate postischemic renal failure. Surgery. 1985 Aug;98(2):207–212. [PubMed] [Google Scholar]
  12. Levenson D. J., Simmons C. E., Jr, Brenner B. M. Arachidonic acid metabolism, prostaglandins and the kidney. Am J Med. 1982 Feb;72(2):354–374. doi: 10.1016/0002-9343(82)90826-9. [DOI] [PubMed] [Google Scholar]
  13. Lifschitz M. D., Barnes J. L. Prostaglandin I2 attenuates ischemic acute renal failure in the rat. Am J Physiol. 1984 Nov;247(5 Pt 2):F714–F717. doi: 10.1152/ajprenal.1984.247.5.F714. [DOI] [PubMed] [Google Scholar]
  14. MATSUMOTO M., SMITH H. T. Japanese and American children's perception of parents. J Genet Psychol. 1961 Mar;98:83–88. doi: 10.1080/00221325.1961.10534355. [DOI] [PubMed] [Google Scholar]
  15. Patrono C., Pugliese F., Ciabattoni G., Patrignani P., Maseri A., Chierchia S., Peskar B. A., Cinotti G. A., Simonetti B. M., Pierucci A. Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest. 1982 Jan;69(1):231–239. doi: 10.1172/JCI110435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sada K., Shirai M., Ninomiya I. Effects of prostaglandin F2 alpha and prostacyclin on pulmonary microcirculation in the cat. J Appl Physiol (1985) 1987 Mar;62(3):1124–1132. doi: 10.1152/jappl.1987.62.3.1124. [DOI] [PubMed] [Google Scholar]
  17. Satoh S., Zimmerman B. G. Influence of the renin-angiotensin system on the effect of prostaglandin synthesis inhibitors in the renal vasculature. Circ Res. 1975 Jun;36(6 Suppl 1):89–96. doi: 10.1161/01.res.36.6.89. [DOI] [PubMed] [Google Scholar]
  18. Schor N., Ichikawa I., Brenner B. M. Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int. 1981 Oct;20(4):442–451. doi: 10.1038/ki.1981.160. [DOI] [PubMed] [Google Scholar]
  19. Spagnuolo P. J., Ellner J. J., Hassid A., Dunn M. J. Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness. J Clin Invest. 1980 Sep;66(3):406–414. doi: 10.1172/JCI109870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]
  21. Welles S. L., Shepro D., Hechtman H. B. Eicosanoid modulation of stress fibers in cultured bovine aortic endothelial cells. Inflammation. 1985 Dec;9(4):439–450. doi: 10.1007/BF00916343. [DOI] [PubMed] [Google Scholar]
  22. Williams T. J., Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature. 1973 Nov 23;246(5430):215–217. doi: 10.1038/246215a0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES